Profile | GDS4284 / 1554565_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 808.963 | 71 |
GSM687648 | Patient 402 control | 821.489 | 71 |
GSM687653 | Patient 403 control | 699.528 | 69 |
GSM687658 | Patient 404 control | 1269.89 | 77 |
GSM687663 | Patient 411 control | 1339.45 | 78 |
GSM687668 | Patient 422 control | 894.471 | 72 |
GSM687673 | Patient 424 control | 1259.7 | 77 |
GSM687678 | Patient 425 control | 786.697 | 70 |
GSM687683 | Patient 427 control | 1487.75 | 80 |
GSM687688 | Patient 428 control | 1235.82 | 77 |
GSM687695 | Patient 441 control | 1043.55 | 76 |
GSM687699 | Patient 443 control | 459.838 | 61 |
GSM687704 | Patient 444 control | 1957.37 | 84 |
GSM687707 | Patient 448 control | 1037.05 | 75 |
GSM687712 | Patient 449 control | 755.992 | 70 |
GSM687719 | Patient 450 control | 910.512 | 72 |
GSM687724 | Patient 451 control | 1744.28 | 82 |
GSM687728 | Patient 452 control | 1559.42 | 81 |
GSM687646 | Patient 401 treated 24h | 740.795 | 69 |
GSM687649 | Patient 402 treated 24h | 900.219 | 72 |
GSM687665 | Patient 411 treated 24h | 1150.56 | 76 |
GSM687651 | Patient 402 treated 4 weeks | 744.148 | 69 |
GSM687667 | Patient 411 treated 4 weeks | 1021.28 | 74 |
GSM687670 | Patient 422 treated 24h | 1276.35 | 77 |
GSM687671 | Patient 422 treated 4 weeks | 1018.82 | 74 |
GSM687654 | Patient 403 treated 24h | 768.078 | 70 |
GSM687675 | Patient 424 treated 24h | 829.634 | 71 |
GSM687685 | Patient 427 treated 24h | 1357.95 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 730.388 | 70 |
GSM687677 | Patient 424 treated 4 weeks | 1467.35 | 79 |
GSM687687 | Patient 427 treated 4 weeks | 1221.9 | 77 |
GSM687692 | Patient 428 treated 4h | 1364.79 | 78 |
GSM687716 | Patient 449 treated 4h | 1059.31 | 75 |
GSM687722 | Patient 450 treated 4h | 953.867 | 73 |
GSM687680 | Patient 425 treated 24h | 1148.85 | 76 |
GSM687690 | Patient 428 treated 24h | 1048.27 | 75 |
GSM687700 | Patient 443 treated 24h | 854.048 | 71 |
GSM687705 | Patient 444 treated 24h | 1963.28 | 84 |
GSM687714 | Patient 449 treated 24h | 796.29 | 71 |
GSM687721 | Patient 450 treated 24h | 440.307 | 60 |
GSM687682 | Patient 425 treated 4 weeks | 1380.23 | 79 |
GSM687694 | Patient 428 treated 4 weeks | 1319.99 | 78 |
GSM687702 | Patient 443 treated 4 weeks | 1087.1 | 75 |
GSM687718 | Patient 449 treated 4 weeks | 1428.16 | 80 |
GSM687723 | Patient 450 treated 4 weeks | 840.96 | 71 |
GSM687661 | Patient 404 treated 4h | 1190.57 | 76 |
GSM687710 | Patient 448 treated 4h | 900.193 | 73 |
GSM687726 | Patient 451 treated 4h | 1319.06 | 78 |
GSM687730 | Patient 452 treated 4h | 7040.49 | 96 |
GSM687660 | Patient 404 treated 24h | 791.744 | 72 |
GSM687697 | Patient 441 treated 24h | 1048.92 | 75 |
GSM687709 | Patient 448 treated 24h | 1088.39 | 76 |
GSM687725 | Patient 451 treated 24h | 1179.36 | 77 |
GSM687729 | Patient 452 treated 24h | 720.067 | 70 |
GSM687727 | Patient 451 treated 4 weeks | 2134.96 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 1204.97 | 77 |